Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Friends of the FCPA Blog — Sandy Sierck and Nick Diamond, who represent the Socio-Economic Rights and Accountability Project in Nigeria — have another good idea. For years, SERAP has been petitioning the DOJ and SEC to return enforcement revenues to the real victims of overseas corruption: the citizens of the corrupt governments.… Continue Reading
Mythili Raman (Image courtesy of C-Span)Acting Assistant Attorney General Mythili Raman of the Justice Department’s Criminal Division is leaving the agency Friday, March 21. But the 17-year DOJ veteran made time the day before her departure to speak to the Global Anti-corruption Compliance Congress in Washington, DC.… Continue Reading
Och-Ziff Capital Management Group said in an SEC filing Wednesday the SEC and DOJ are investigating whether it violated the Foreign Corrupt Practices Act in connection with an investment from a sovereign wealth fund.… Continue Reading
Head office of Marubeni in Chiyoda-Ku, Tokyo, Japan (courtesy of Wikipedia)Japan’s Marubeni Corporation pleaded guilty Wednesday to eight FCPA charges, admitting it bribed Indonesian officials to win an electricity contract for itself and a partner, Alstom SA.… Continue Reading
Part One of this series discussed the difficulties compliance professionals face in demonstrating return on investment to senior management or the board. This second and final part looks at how compliance professionals can prove their team’s ROI.… Continue Reading
SciClone Pharmaceuticals Inc. said it has reserved $2 million for penalties related to an ongoing Foreign Corrupt Practices Act probe.
The California-based phrama said in its annual report last week that a settlement of that size was “probable.”… Continue Reading
